Affirma Capital has sold its stake in Tirupati Medicare to Kotak Alternate Asset Managers Limited
Tirupati Medicare
Founded in 2005, Tirupati Group is one of India’s largest nutraceutical CDMOs, with a diversified portfolio across various therapy areas. The company offers an extensive range of products in nutraceuticals, pharmaceuticals and ayurveda. Backed by a team of over 2,000 employees, Tirupati Group is the preferred partner for leading global nutraceutical and pharma companies.
The Deal
The transaction involved a secondary stake sale by Affirma Capital, small secondary stake sale by Promoters along with a primary infusion by Kotak Alternate Asset Managers in the company. Lincoln International served as financial advisor to Tirupati Group and Affirma Capital, guiding the shareholders through the sale process.
Our Perspective
Gaurav Marathe, Managing Director & head of Lincoln India, commented, “We are extremely pleased to have advised the shareholders and founders of Tirupati Group on this transaction. Tirupati Group’s exceptional value proposition, innovation and strong customer loyalty will undoubtedly sustain its market leadership. We look forward to witnessing the company’s continued success in its next chapter.”
Meet our Senior Team
View More Transactions in Healthcare
Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.